Physician

Timothy Fu

According to 2025 Medicare claims, Timothy Fu (NPI: 1669961645) practices hematology/oncology in the Austin-Round Rock-San Marcos, TX market, with the plurality of this provider's patient population coming from Travis, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1972770303; TIN: 752131429) and primary practice location at 78731-4214.

Fu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 86 traditional Medicare patients, billed 7,997 HCPCS/CPT codes, and received $133,100 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 30 prescription claims across 18 beneficiaries totaling $26,394 in drug costs. Open Payments data shows 2 records totaling $30. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $3,873 to $26,394. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$67K$133K2024 Medicare payment: $133,100 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024867,997$133,100

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$13K$26K2018 Drug cost: $3,873 (USD; Tot_Drug_Cst)2019 Drug cost: $2,535 (USD; Tot_Drug_Cst)2020 Drug cost: $640 (USD; Tot_Drug_Cst)2021 Drug cost: $2,372 (USD; Tot_Drug_Cst)2022 Drug cost: $186 (USD; Tot_Drug_Cst)2023 Drug cost: $361 (USD; Tot_Drug_Cst)2024 Drug cost: $26,394 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R37$3,873
2019N/R40$2,535
2020N/R15$640
2021N/R15$2,372
20221113$186
20231320$361
20241830$26,394

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less1717$105
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1520$102
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes1111$102
96375Injection of additional new drug or substance into vein1421$12
36415Insertion of needle into vein for collection of blood sample1223$9

Top 5 Part D drugs in 2024

By total drug costs.

Part D summary data is connected for 2024, but public drug-level costs are not available, so a Top 5 by total drug costs cannot be shown.

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$30Celgene Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Timothy Fu?

Tedicare shows public-source Medicare data for Timothy Fu (NPI 1669961645), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Timothy Fu have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Timothy Fu?

Timothy Fu is linked to TEXAS ONCOLOGY PA (billing NPI 1972770303) in the available physician profile data.

Does Timothy Fu have Open Payments data?

Timothy Fu has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.